<?xml version="1.0" encoding="UTF-8"?>
<p>The studied compounds could be divided into 3 groups considering structure fragments: 
 <list list-type="order">
  <list-item>
   <p>
    <italic>1st group</italic>: twenty-five representatives of two cationic moieties containing 1,4-dihydropyridines (compounds 
    <bold>1</bold>–
    <bold>25</bold> in 
    <xref rid="tab1" ref-type="table">Table 1</xref>) and, additionally, four cationic moieties containing 1,4-dihydropyridine (compound 
    <bold>26</bold> in 
    <xref rid="tab1" ref-type="table">Table 1</xref>) and one as an oxidized form—two cationic moieties containing pyridine (compound 
    <bold>27</bold> in 
    <xref rid="tab1" ref-type="table">Table 1</xref>)
   </p>
  </list-item>
  <list-item>
   <p>
    <italic>2nd group</italic>: eleven representatives of 3,4-dihydro-2(1
    <italic>H</italic>)-pyridones containing a cationic moiety as an isomeric 3,4-dihydropyridine structure with an additional intracyclic carbonyl group, i.e., the N-
    <italic>β</italic>-carbonylvinylamido system (compounds 
    <bold>28</bold>–
    <bold>38</bold> in 
    <xref rid="tab2" ref-type="table">Table 2</xref>)
   </p>
  </list-item>
  <list-item>
   <p>
    <italic>3rd group</italic>: ten representatives of cationic 2-amino-3-alkoxycarbonylalkylammonium derivatives as acyclic, open-chain analogues of cyclic 1,4-DHPs (compounds 
    <bold>39</bold>–
    <bold>48</bold> in 
    <xref rid="tab3" ref-type="table">Table 3</xref>)
   </p>
  </list-item>
 </list>
</p>
